These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 1687073)
1. [New trends in the treatment of hemodynamic disorders in liver cirrhosis]. Vorob'ev LP; Maev IV Klin Med (Mosk); 1991 Sep; 69(9):11-4. PubMed ID: 1687073 [TBL] [Abstract][Full Text] [Related]
2. [Medical therapy of portal hypertension due to liver cirrhosis]. Cerini R; Sperandeo M; Varriale A; De Rosa ML; Cacciatore L Recenti Prog Med; 1991 Feb; 82(2):91-9. PubMed ID: 2034876 [TBL] [Abstract][Full Text] [Related]
7. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation. Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Cavasin L; Gatta A Aliment Pharmacol Ther; 2005 Sep; 22(5):433-9. PubMed ID: 16128681 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic assessment of pharmacological response in the treatment of portal hypertension: a need to know. Grace ND Am J Gastroenterol; 2000 Aug; 95(8):1862-4. PubMed ID: 10950027 [No Abstract] [Full Text] [Related]
9. [The effect of calcium antagonists on pulmonary hemodynamics in patients with chronic bronchitis with manifest and latent pulmonary hypertension]. Volkova LI Ter Arkh; 1989; 61(8):50-3. PubMed ID: 2588166 [TBL] [Abstract][Full Text] [Related]
10. [The effect of nitrosorbide, korinfar and obzidan on the hemodynamics of patients with chronic hepatitis and liver cirrhosis based on the data acute drug trials]. Vorob'ev LP; Maev IV Farmakol Toksikol; 1991; 54(5):54-7. PubMed ID: 1800153 [TBL] [Abstract][Full Text] [Related]
11. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis]. Fedulenkova LV; Drozdov VN; Mikheeva OM; Petrakov AV Eksp Klin Gastroenterol; 2008; (5):37-41. PubMed ID: 19145915 [No Abstract] [Full Text] [Related]
12. Response to Sildenafil in a Patient With Coexisting Post-Liver Transplant Portopulmonary Hypertension and Hepatopulmonary Syndrome. Turgeon RD; Hussaini T; Partovi N; Erb SR; Nador R; Marquez Azalgara V; Yoshida E Exp Clin Transplant; 2017 Dec; 15(6):693-695. PubMed ID: 27001306 [TBL] [Abstract][Full Text] [Related]
13. [Use of nitrates in the symptomatic treatment of pulmonary hypertension]. Dubiel JP Folia Med Cracov; 1989; 30(1-2):39-43. PubMed ID: 2701818 [TBL] [Abstract][Full Text] [Related]
14. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacological treatment of the portal hypertension]. Castañeda Romero B Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():64-5. PubMed ID: 17471863 [No Abstract] [Full Text] [Related]
17. [Disorders of regional blood circulation in systemic scleroderma: early diagnosis and possibility of its correction]. Bagirova GG; Doroshenko IuA Ter Arkh; 1988; 60(4):105-9. PubMed ID: 3394080 [TBL] [Abstract][Full Text] [Related]
18. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Bosch J; Kravetz D; Rodes J Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897 [TBL] [Abstract][Full Text] [Related]
19. Oral administration of nipradilol and the acute and chronic splanchnic hemodynamic effects of a new beta-blocker with nitrovasodilating properties in patients with liver cirrhosis. Sugano S; Kawafune T; Suzuki T; Kubota M; Okajima T; Sumino Y; Akita H Am J Gastroenterol; 1995 May; 90(5):788-93. PubMed ID: 7733089 [TBL] [Abstract][Full Text] [Related]